Now, researchers at Harvard University have built a mechanical implant that prompts muscle contraction and could help to slow this atrophy. Known as MAGENTA (mechanically active gel-elastomer-nitinol ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA ... back region on each side of the spinal cord ...

Patients with muscle wasting had significantly lower values for muscle strength, as well as lower total peak oxygen consumption, lower exercise time and lower left ventricular ejection fraction.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA ... back region on each side of the spinal cord ...

Evrysdi is the only FDA-approved, noninvasive, disease-modifying treatment for spinal muscular atrophy. The tablets offer similar safety and efficacy as the original oral solution. The FDA has ...

Skeletal muscle constitutes approximately 40% of total body mass ... which causes skeletal muscle atrophy. The current study identified BCAA catabolic dysfunction and accumulation as key metabolic ...

Objective: To investigate atrophy and weakness of the quadriceps femoris muscle group in patients with PFPS using measures of cross-sectional area and peak extension torque. Methods: A total of 57 ...

Yet over the month-long pilot study, “they were getting better and better.” Spinal muscle atrophy or SMA is a genetic disease that gradually destroys motor neurons, nerve cells in the spinal ...